In a big week for W.L. Gore & Associates Inc., the company reported plans to acquire Conformal Medical Inc. and received U.S.
PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...
John MacDonald, 73, agreed to take part in the study after he was rushed to the Golden Jubilee Hospital when he suffered a ...
John MacDonald, 73, took part in a clinical trial using gene therapy to extend the lifespan of blood vessels in the heart ...
A retired HGV driver was the first person in the world to take part in a clinical trial to extend the lifespan of blood ...
W. L. Gore & Associates has secured FDA approval for the GORE VIABAHN FORTEGRA Venous Stent — previously known as the GORE ...
A final option, less commonly used, is a technique called atherectomy. This treatment uses a device that cuts or grinds away the hardened deposition (atheroma) within the artery. Atherectomy is less ...
Gore & Associates announced FDA approval of the Gore Viabahn Fortegra venous stent—previously known as the Gore Viafor ...
The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...
The MarketWatch News Department was not involved in the creation of this content. LAS VEGAS, Nov. 2, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback